|
|
Article: Inflammatory Breast Cancer Research Foundation Expands Collaboration With SIDMAP.
- Article from:
- PR Newswire
- Article date:
- January 11, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LOS ANGELES, Jan. 11 /PRNewswire/ -- Citing opportunities for early detection and therapeutic target discovery not available with other techniques, the Inflammatory Breast Cancer Research Foundation (ibcRF) has selected SIDMAP, a drug development and drug testing company, to further expand its work in understanding biomarkers for inflammatory breast cancer.
Previously, Dr. Laszlo Boros, Associate Professor of Pediatrics at Harbor U.C.L.A. and one of the founders of SIDMAP, had worked with ibcRF to assist its efforts to better understand the disease and develop effective tools for early detection.
"We are very excited about our continued collaboration ...